These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 3413493)
21. Funding for gene therapy. Chabner BA; Levy R Science; 1993 May; 260(5110):877-8. PubMed ID: 8338577 [No Abstract] [Full Text] [Related]
22. AACR-NCI-EORTC-15th symposium molecular targets and cancer therapeutics: enzyme inhibitors and anti-angiogenics. Mayfield R IDrugs; 2004 Jan; 7(1):19-21. PubMed ID: 14968809 [No Abstract] [Full Text] [Related]
23. Jeffrey White directs NCI's new Office of Alternative Medicine. Interview by Nancy Nelson. White J J Natl Cancer Inst; 1999 Feb; 91(4):313-4. PubMed ID: 10050863 [No Abstract] [Full Text] [Related]
24. Bridging the gap between research and practice. Braillon A Am J Med; 2011 Nov; 124(11):e15. PubMed ID: 21684514 [No Abstract] [Full Text] [Related]
25. Cancer immunotherapy: breaking the barriers to harvest the crop. Pardoll D; Allison J Nat Med; 2004 Sep; 10(9):887-92. PubMed ID: 15340404 [TBL] [Abstract][Full Text] [Related]
26. Alternative therapies getting notice through Best Case Series Program. Vanchieri C J Natl Cancer Inst; 2000 Oct; 92(19):1558-60. PubMed ID: 11018087 [No Abstract] [Full Text] [Related]
27. Clinical trials: a recent emphasis in the prevention program of the National Cancer Institute. DeWys WD; Greenwald P Semin Oncol; 1983 Sep; 10(3):360-4. PubMed ID: 6665563 [No Abstract] [Full Text] [Related]
28. Hatch batters NCI with straus case. Sun M Science; 1981 Jun; 212(4501):1366. PubMed ID: 7015513 [No Abstract] [Full Text] [Related]
29. AACR-NCI-EORTC-15th symposium molecular targets and cancer therapeutics: emerging targets and pharmacodynamics. Mayfield R IDrugs; 2004 Jan; 7(1):22-5. PubMed ID: 14968810 [No Abstract] [Full Text] [Related]
30. Medicine and Public Affairs. "New broom" at the Cancer Institute? Greenberg DS N Engl J Med; 1977 Sep; 297(12):679-80. PubMed ID: 895787 [No Abstract] [Full Text] [Related]
31. Second round of NCI funds goes to other institutes. Vanchieri C; Flach J J Natl Cancer Inst; 1992 Aug; 84(15):1145-7. PubMed ID: 1635078 [No Abstract] [Full Text] [Related]
32. Medicine and Public Affairs. The cancer program: a new burst of criticism. Greenberg DS N Engl J Med; 1975 Dec; 293(26):1379-80. PubMed ID: 1186841 [No Abstract] [Full Text] [Related]
34. Cancer centers and cancer research: the need for recognition and increased funding. Durbin RJ Int J Cell Cloning; 1990 Nov; 8(6):387-91. PubMed ID: 2273294 [No Abstract] [Full Text] [Related]
35. Klausner follows own advice at NCI. Marshall E Science; 1995 Aug; 269(5226):912-3. PubMed ID: 7638609 [No Abstract] [Full Text] [Related]
36. Cancer problems lead list for potential medical marijuana research studies. Smigel K J Natl Cancer Inst; 1997 Sep; 89(17):1255. PubMed ID: 9293912 [No Abstract] [Full Text] [Related]
37. Cancer research program strategy and planning--the use of contracts for program implementation. Baker CG J Natl Cancer Inst; 1977 Aug; 59(2 Suppl):651-69. PubMed ID: 328910 [No Abstract] [Full Text] [Related]
38. National cancer institute perspectives. Wong RS; Brechbiel MW Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S96-9. PubMed ID: 16979449 [TBL] [Abstract][Full Text] [Related]
40. Cancer research--a study of man and his environment. Marston RQ Am J Public Health Nations Health; 1969 Sep; 59(9):1589-94. PubMed ID: 5817600 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]